Clinical Trials
11 trialsNCT04745910 2026-05-06
Pegloticase for the Reduction of Uric Acid in Patients With Tumor Lysis Syndrome
M.D. Anderson Cancer Center
Phase 4 Completed
NCT04952766 2025-12-23
EREVA
Centre Hospitalier Régional d'Orléans
Phase 4 Completed
NCT03649334 2020-09-09
Ketamine-ketorolac Versus Fentanyl- Ketorolac I.M in Children During Bone Marrow Biopsy
Mansoura University
Phase 4 Completed
NCT02149329 2019-09-25
SHORT
Amsterdam UMC, location VUmc
Phase 4 Completed
NCT00361140 2017-03-03
Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT)
H. Lee Moffitt Cancer Center and Research Institute
Phase 4 Completed
NCT02880709 2016-08-29
The Effect of Special Diets in Hematological Cancer Patients
University of Copenhagen
Phase 4 Completed
NCT01416025 2016-08-18
VoriTDM
Johns Hopkins University
Phase 4 Completed
NCT02372357 2015-03-03
A New Dosing Regimen for Posaconazole Prophylaxis in Children Based on Body Surface Area
Universitaire Ziekenhuizen KU Leuven
Phase 4 Completed
NCT00500578 2012-08-01
Intermittent Use of Aerosolized Ribavirin for Treatment of RSV
M.D. Anderson Cancer Center
Phase 4 Completed
NCT01198236 2011-10-14
Efficacy of Itraconazole as Secondary Prophylaxis in Patients Undergoing Allogeneic Stem Cell Transplantation or Chemotherapy With Prior Invasive Fungal Infection
Zhejiang University
Phase 4 Completed
NCT00067730 2007-12-07
A Safety Evaluation of Drotrecogin Alfa (Activated) in Patients With Blood Cancer, Severe Infection Related to Bone Marrow Transplantation
Eli Lilly and Company
Phase 4 Completed